Thousands of lawsuits against Risperdal, a J & J antipsychotic drug, have been reactivated

Recently, the health and Health Commission of Hainan Province issued the notice on printing and distributing the detailed rules for the implementation of subsidy funds for basic public health service projects in Hainan Province According to the latest national basic public health service work content in 2019, the specific arrangement on the use of public health subsidy funds is made clear (grassroots doctors' commune) Yesterday, panshengzi filed an initial public offering with the SEC, with plans to raise up to $100m Pan Shengzi was founded in 2015 Through the business combination of "product + service" and "prevention and screening + personalized diagnosis and treatment + drug research and development services", it provides molecular analysis and diagnosis services for cancer patients, hundreds of scientific research institutions, hospitals and pharmaceutical enterprises (billion euro) Recently, Sinopharm group announced its first three quarters results in 2019, with sales revenue of 16.761 billion yuan, up 27.5% year on year Among them, the sales revenue of innovative drugs reached 9.525 billion yuan, a year-on-year increase of 51.9%, accounting for more than 50% of the total revenue In addition, the R & D cost has reached 1.5 billion yuan At present, there are more than 300 research projects, mainly focusing on cardiovascular and cerebrovascular diseases, anti-tumor, diabetes, mental and neurological diseases and anti infection fields (meter net) Can a complete set of health tests be completed in 20 minutes with only 7 drops of blood? Truvian sciences is such a cutting-edge company dedicated to the development of automatic desktop testing system to use a small amount of blood for a full range of health tests Recently, the company announced the completion of round B financing of US $27.1 million (chuangjianhui) On November 22, Shandong Xinhua Pharmaceutical released a notice that captopril tablets (25mg) of the company had received the approval document for supplementary drug application issued by the State Food and Drug Administration and passed the consistency evaluation, becoming the third enterprise in China that had ever been evaluated; on the same day, Ibuprofen Sustained Release Capsule (0.3g) of Shanghai Xinyi balance Pharmaceutical Co., Ltd had also been evaluated successfully (Insight database) Today, biomarin pharmaceutical announced that it has submitted to the European drug administration an application for marketing authorization for the gene therapy valocogene roxaparvovec It is understood that this is the first application of gene therapy for hemophilia in the world (yaomingkant) Today, the U.S FDA announced approval of AstraZeneca's Btk inhibitor, calsequence (acalabrutinib), as an initial or follow-up treatment for adult patients with chronic lymphoid leukemia or small cell lymphoma (yaomingkant) Today, the U.S FDA announced that it has approved the listing of xcopri (cenobamate tables) developed by SK life sciences to treat focal epilepsy in adults (yaomingkant) On November 20, the listing application of lilaluptide injection (acceptance No.: cyhs1900746) of Shenzhen Hanyu Pharmaceutical Co., Ltd was undertaken by the drug audit center This time, it was listed according to the new 4 types of generic drugs, which was used to control the blood sugar of adult type 2 diabetic patients (Insight database) On November 20, Lepu medical released a notice that Lepu hengjiuyuan Pharmaceutical Co., Ltd., a holding subsidiary of Lepu, received the approval document for supplementary application of drugs on valsartan capsule approved and issued by the State Food and drug administration The drug passed the consistency evaluation, and Lepu Hengyuan pharmaceutical industry is the first enterprise in China that has been evaluated According to the data of minenet, in 2018, the sales volume of terminal valsartan capsules in public medical institutions in China reached 3.723 billion yuan (meter net) Sanofi is considering selling its $30 billion consumer health business, or setting up a joint venture or IPO, according to Biospace, a foreign website Paul Hudson, Sanofi's new chief executive on September 1, is expected to meet with investors in Cambridge, Massachusetts, on December 10 about how the consumer health business will be handled (Sina Medical News) In recent years, Johnson & Johnson has been dealing with a number of product lawsuits, from opiates to talcum powder products to medical devices On November 20, the Supreme Court of Pennsylvania ruled that it did not agree that the lower court dismissed two lawsuits against Risperdal, the J & J antipsychotic, on the grounds of statutory limitation According to law.com, the decision will reactivate thousands of other Risperdal lawsuits for breast development in men (Sina Medical News) Recently, researchers from IFM therapeutics published the latest research in the journal Nature, proving that the activation of NLRP3 inflammatory body is an important factor driving tau protein pathology in Alzheimer's disease and neurodegenerative diseases caused by tau protein This study suggests that these patients may benefit from NLRP3 antagonists IFM therapeutics is a biomedical company specializing in the development of innovative therapies for the regulation of innate immune response, the treatment of inflammatory diseases and cancer (yaomingkant) Recently, the State Food and drug administration has successively issued the notice on the revision of the drug specifications of cerebrosine and carnosine injection and compound osteopeptide injection, further standardizing and completing the drug specifications From 2019 to now, the State Food and drug administration has issued 22 amendments to drug specifications, involving 36 generic drugs, including 13 injections (meter net)